Clinical Trial Update: Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating colchicine for treatment of patients with acute myocardial infarction and inflammatory response has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED